Biochemistry and Physiology of Cardiac Calcium Channels
The voltage-dependent slow calcium channel allows the passive movement of calcium across the plasma membrane of a variety of excitable cells and regulates thereby directly or indirectly the cytosolic calcium concentration of these cells (for a review see Reuter 1984). In cardiac muscle, opening of these channels depends on the depolarization of the membrane and is facilitated by phosphorylation of a membrane protein (Osterrieder et al. 1982). In vascular smooth muscle and in other tissues, a second type of calcium channel has been postulated which is regulated directly or indirectly by hormone receptors. These channels appear to differ in many respects from the voltage-operated calcium channels. Recently, a third type of calcium channel has been described which differs markedly in its electrophysiological characteristics from the other two types (Carbone and Lux 1984, Armstrong and Matteson 1985). The calcium conductance of the voltage- and receptor-operated channel is blocked by a heterogenous group of compounds, for which the term “calcium antagonists” (Fleckenstein 1977), calcium entry blockers, or calcium channel blockers has been introduced. Among these compounds are the phenylalkylamines verapamil, gallopamil, and desmethoxyvera-pamil, the dihydropyridines nitrendipine, nimodipine, and nifedipine, and the benzothiazepine diltiazem.
KeywordsVerapamil Nifedipine Lanthanum Stim Allo
Unable to display preview. Download preview PDF.
- Glossmann H, Ferry D, Goll A (1985) Proc IX Int Congr Pharmacol London 2:329–335Google Scholar
- Jones LR, Cala SE (1981) J Biol Chem 256:11009–11018Google Scholar
- Millard RW, Grupp G, Grupp IZ, Di Salvo J, De Pover A, Schwartz A (1983) Circ Res 52:Suppl I, 29–39Google Scholar
- Pelzer D, Hescheler J, Cavalie A, Trautwein W (1985) Pfluegers Arch 403:Suppl R 48Google Scholar
- Reuter H (1983) Nature (London) 569–574Google Scholar